The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women
出版年份 2015 全文链接
标题
The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 8, Issue 6, Pages 769-784
出版商
Informa UK Limited
发表日期
2015-10-20
DOI
10.1586/17512433.2015.1099432
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
- (2015) Robert R. Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis
- (2015) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis
- (2015) Santiago Palacios et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Salmon Calcitonin Use and Associated Cancer Risk
- (2014) Robert A. Overman et al. ANNALS OF PHARMACOTHERAPY
- Questioning the association between bisphosphonates and atypical femoral fractures
- (2014) Michael Pazianas et al. Annals of the New York Academy of Sciences
- Treatment of postmenopausal osteoporosis with odanacatib
- (2014) Roland D Chapurlat EXPERT OPINION ON PHARMACOTHERAPY
- Declining Rates of Osteoporosis Management Following Fragility Fractures in the U.S., 2000 Through 2009
- (2014) Akhila Balasubramanian et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
- (2014) Nicole C Wright et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial
- (2014) JoAnn V. Pinkerton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Menopausal hormone therapy use in 17 European countries during the last decade
- (2014) Lieveke Ameye et al. MATURITAS
- Romosozumab in Postmenopausal Women with Osteopenia
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
- (2014) H. G. Bone et al. OSTEOPOROSIS INTERNATIONAL
- Beneficial effects of vitamin D on falls and fractures: is cognition rather than bone or muscle behind these benefits?
- (2014) C. Marcelli et al. OSTEOPOROSIS INTERNATIONAL
- Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference
- (2014) V. Fadda et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002–2012
- (2013) Diane K. Wysowski et al. BONE
- Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review
- (2013) Erik F. Eriksen et al. BONE
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials
- (2013) JoAnn E. Manson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts
- (2013) Beatrice J Edwards et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
- (2013) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: Results of a 7-year, randomized, placebo-controlled, phase 3 study
- (2013) Santiago Palacios et al. MATURITAS
- Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model
- (2013) Kelly F. Ethun et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women
- (2013) Chrisandra L. Shufelt et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Breast Effects of Bazedoxifene-Conjugated Estrogens
- (2013) JoAnn V. Pinkerton et al. OBSTETRICS AND GYNECOLOGY
- Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis
- (2013) M. Tadrous et al. OSTEOPOROSIS INTERNATIONAL
- Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate
- (2013) P. Cacoub et al. OSTEOPOROSIS INTERNATIONAL
- Risk of Breast Cancer by Type of Menopausal Hormone Therapy: a Case-Control Study among Post-Menopausal Women in France
- (2013) Emilie Cordina-Duverger et al. PLoS One
- Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
- (2013) Stephen Gehlbach et al. PLoS One
- Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens
- (2013) Nicholas L. Smith et al. JAMA Internal Medicine
- A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis
- (2013) Luisella Cianferotti et al. Therapeutic Advances in Musculoskeletal Disease
- Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use
- (2012) Raphael P. H. Meier et al. ARCHIVES OF INTERNAL MEDICINE
- The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women
- (2012) Sibylle P. Hämmerle et al. BONE
- Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis
- (2012) K. Henriksen et al. BONE
- Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls
- (2012) Jörg Schilcher et al. BONE
- Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice
- (2012) Patricia Sieber et al. CLINICAL DRUG INVESTIGATION
- Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective
- (2012) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Incidence of atypical nontraumatic diaphyseal fractures of the femur
- (2012) Richard M Dell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial
- (2012) Joanne L Welton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
- (2012) Roland Baron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study
- (2012) S. SWEETLAND et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A decade of postmenopausal hormone therapy prescribing in the United States
- (2012) Amy R. Steinkellner et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Bisphosphonates for Osteoporosis — Where Do We Go from Here?
- (2012) Marcea Whitaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Committee Opinion No. 531
- (2012) OBSTETRICS AND GYNECOLOGY
- Individualizing osteoporosis therapy
- (2012) S. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
- (2012) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
- (2012) Athanasios Anastasilakis Therapeutics and Clinical Risk Management
- Defining Ethnic and Racial Differences in Osteoporosis and Fragility Fractures
- (2011) Jane A. Cauley CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
- (2011) Laura Y. Park-Wyllie JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor and Cyclin D1
- (2011) J. S. Lewis-Wambi et al. MOLECULAR PHARMACOLOGY
- Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
- (2011) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
- (2011) N. B. Watts et al. OSTEOPOROSIS INTERNATIONAL
- Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
- (2011) G. Bianchi et al. OSTEOPOROSIS INTERNATIONAL
- Impact of Bisphosphonates on the Risk of Atrial Fibrillation
- (2010) Patricia A. Howard et al. American Journal of Cardiovascular Drugs
- Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis
- (2010) Claus Christiansen et al. BMC MUSCULOSKELETAL DISORDERS
- Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women
- (2010) Valérie Olié et al. CURRENT OPINION IN HEMATOLOGY
- Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
- (2010) Chris R. Cardwell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
- (2010) Rowan T. Chlebowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of osteoporosis in postmenopausal women
- (2010) &NA; MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Estrogen and progestogen use in postmenopausal women
- (2010) &NA; MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
- (2010) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of Bisphosphonates in the Treatment of Osteoporosis
- (2009) Robert R. Recker et al. AMERICAN JOURNAL OF MEDICINE
- Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
- (2009) John A. Kanis et al. BONE
- Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile
- (2009) Rogerio A. Lobo et al. FERTILITY AND STERILITY
- Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
- (2009) Robert Lindsay et al. FERTILITY AND STERILITY
- Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy
- (2009) James H. Pickar et al. FERTILITY AND STERILITY
- Potential mediators of the mortality reduction with zoledronic acid after hip fracture
- (2009) Cathleen S Colón-Emeric et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
- (2009) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
- (2009) Peter Kenemans et al. LANCET ONCOLOGY
- Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens
- (2009) JoAnn V. Pinkerton et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Reports of Esophageal Cancer with Oral Bisphosphonate Use
- (2009) Diane K. Wysowski NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bleeding with menopausal hormone therapy
- (2008) Martha Hickey et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis
- (2008) René Rizzoli et al. BONE
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effects of Tibolone in Older Postmenopausal Women
- (2008) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of parathyroid hormone for the treatment of osteoporosis
- (2008) Paul D. Miller Current Osteoporosis Reports
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started